Physician profile
Mark E Kleinman
NPI 1063676310
$18,010.84
in general payments reported to CMS, 2019-2025
19 companies · $14K in 2025
The $14K reported for 2025 was more than what 92% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.12 · 2020: $30.36 · 2021: $138 · 2022: $2,410 · 2023: $299 · 2024: $619 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Travel and Lodging: $1,805 · Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,155.00 |
| Travel and Lodging | $1,804.91 |
| Food and Beverage | $1,414.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $14,356.28 | 2024-2025 | Eylea Hd |
| Apellis Pharmaceuticals, INC. | $2,290.19 | 2022-2024 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $413.96 | 2019-2024 | Eylea Hd, Eylea |
| Alcon Vision LLC | $275.59 | 2024-2025 | Unity, Constellation |
| Genentech USA, INC. | $217.97 | 2019-2025 | Vabysmo |
| Alimera Sciences, INC. | $198.95 | 2021-2024 | Iluvien, Yutiq |
| Abbvie INC. | $52.34 | 2022-2024 | |
| Carl Zeiss Meditec USA, INC. | $41.56 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.73 | 2021 | |
| Sandoz INC. | $23.08 | 2024 | Cimerli |
| Bausch & Lomb Americas INC. | $22.36 | 2023 | Xipere, Visudyne |
| Astellas Pharma US INC | $22.10 | 2024 | Izervay |
| Coherus Oncology, INC. | $20.92 | 2023 | |
| Biogen, INC. | $20.17 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.29 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $12.35 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Kleinman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.